Antogen

Range Biotechnologies

This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.

Exogene

This biotechnology company develops artificial intelligence and screening platforms to discover T-cell receptor-based cell therapies for oncology researchers and pharmaceutical developers.

Anthrogen

This company develops artificial intelligence models and experimental infrastructure to design modular proteins and biological machines for healthcare, industrial and climate applications.

Haptena Therapeutics

This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.

Alithea Biotechnology GmbH

This company develops immunopeptidomics software and laboratory services for pharmaceutical, biotechnology and academic organisations developing cancer immunotherapies and vaccines.

Cartography

This precision immunotherapy company develops targeted cancer therapies and an antigen atlas for medical researchers to identify cell-specific treatment targets.

Anto Biosciences

This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.

DC Biosciences

DC Biosciences provides proteomics services and research tools to pharmaceutical and biotechnology companies to support drug discovery and development processes.